# Fecal Microbiota Transplantation For The Treatment Of Gastro-Intestinal Acute GVHD

> **NCT04059757** · PHASE2 · WITHDRAWN · sponsor: **Leland Metheny**

## Conditions studied

- Gastro-Intestinal Acute Graft Versus Host Disease (GI-aGVHD)

## Interventions

- **BIOLOGICAL:** Fecal Microbiota Transplantation (FMT)

## Key facts

- **NCT ID:** NCT04059757
- **Lead sponsor:** Leland Metheny
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-05
- **Primary completion:** 2023-06
- **Final completion:** 2023-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Drugs unavailable
- **Last updated:** 2022-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04059757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04059757, "Fecal Microbiota Transplantation For The Treatment Of Gastro-Intestinal Acute GVHD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04059757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*